The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients-Reference-Cited by-同舟云学术

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Published:2014 Issue:1 Volume:20 Page:38
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Jung Hee Jae¹,Kim Young Seok¹,Kim Sang Gyune¹,Lee Yun Nah¹,Jeong Soung Won²,Jang Jae Young²,Lee Sae Hwan³,Kim Hong Soo³,Kim Boo Sung¹

Affiliation:

1. Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Soonchunhyang University College of Medicine, Bucheon, Korea.

2. Institute for Digestive Research, Department of Internal Medicine, Soonchunhyang University Hospital Seoul, Soonchunhyang University College of Medicine, Seoul, Korea.

3. Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Soonchunhyang University College of Medicine, Cheonan, Korea.

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://synapse.koreamed.org/pdf/10.3350/cmh.2014.20.1.38

Reference33 articles.

1. Recent trends in the treatment of chronic hepatitis C

2. Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients

3. Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication

4. Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients

5. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals;F1000Research;2022-06-13

2. The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments;Biomedicines;2021-10-17

3. Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir;European Journal of Gastroenterology & Hepatology;2020-08-14

4. Lipid profile changes after direct acting antiviral treatment in different genotypes of chronic hepatitis C virus‐infected patients;Advances in Digestive Medicine;2020-08-07

5. Effect of HCV treatment response on insulin resistance: A systematic review and meta‑analysis;Experimental and Therapeutic Medicine;2019-09-11